LRIG1 Antibody [Alexa Fluor® 488]

D3 mouse embryonic stem cell line was stained with Goat Anti-Mouse LRIG1 Alexa Fluor® 488-conjugated Antigen Affinity-purified Polyclonal Antibody (Catalog # FAB3688G, filled histogram) or isotype control antibody (Catalog # IC108G, open histogram). View our protocol for Staining Membrane-associated Proteins.

• Reactivity: Mu
• Applications: Flow
• Clonality: Polyclonal
• Host: Goat
• Conjugate: Alexa Fluor 488

LRIG1 Antibody [Alexa Fluor® 488] Summary

• Immunogen: Mouse myeloma cell line NS0-derived recombinant mouse LRIG1
  Ala37-Thr794
  Accession # P70193
• Specificity: Detects mouse LRIG1 in direct ELISAs and Western blots. In direct ELISAs and Western blots, approximately 5% cross-reactivity with recombinant human LRIG3 is observed.
• Source: N/A
• Isotype: IgG
• Clonality: Polyclonal
• Host: Goat
• Gene: Lrig1
• Purity Statement: Antigen Affinity-purified

Applications/Dilutions

• Dilutions:
  • Flow Cytometry 5 uL/10^6 cells

Packaging, Storage & Formulations

• Storage: Protect from light. Do not freeze.
  • 12 months from date of receipt, 2 to 8 °C as supplied.
• Buffer: Supplied in a saline solution containing BSA and Sodium Azide.
• Preservative: Sodium Azide

Notes

This product is provided under an agreement between Life Technologies Corporation and R&D Systems, Inc, and the manufacture, use, sale or import of this product is subject to one or more US patents and corresponding non-US equivalents, owned by Life Technologies Corporation and its affiliates. The purchase of this product conveys to the buyer the non-transferable right to use the purchased amount of the product and components of the product only in research conducted by the buyer (whether the buyer is an academic or for-profit entity). The sale of this product is expressly conditioned on the buyer not using the product or its components (1) in manufacturing; (2) to provide a service, information, or data to an unaffiliated third party for payment; (3) for therapeutic, diagnostic or prophylactic purposes; (4) to resell, sell, or otherwise transfer this product or its components to any third party, or for any other commercial purpose. Life Technologies Corporation will not assert a claim against the buyer of the infringement of the above patents based on the manufacture, use or sale of a commercial product developed in research by the buyer in which this product or its components was employed, provided that neither this product nor any of its components was used in the manufacture of such product. For information on purchasing a license to this product for purposes other than research, contact Life Technologies Corporation, Cell Analysis Business Unit, Business Development, 29851 Willow Creek Road, Eugene, OR 97402, Tel: (541) 465-8300. Fax: (541) 335-0354.

This product is produced by and ships from R&D Systems, Inc., a Bio-Techne brand.

Alternate Names for LRIG1 Antibody [Alexa Fluor® 488]

• D6Bwg0781e
• Img
• LIG1
• LIG-1
• LRIG1

Background

LRIG1 (Leucine-rich Repeats and Ig-like domains-1), also known as LIG-1, is an approximately 130-145 kDa glycoprotein that belongs to the LRIG gene family.  It is widely expressed, and appears on the surface of prostatic epithelium, endothelial cells, vascular and visceral smooth muscle, mammary epithelium, cardiac muscle, keratinocytes and neurons.  LRIG1 is believed to negatively regulate the ErbB family of receptors.  In particular, and in a ligand-independent manner, LRIG1 complexes with all four ErbBs, promoting their ubiquitination and decreasing their number.  Alternatively, LRIG1 is suggested to bind to the ErbBs, preventing their dimerization and signal transduction.  Mature mouse LRIG1 is a 1057 amino acid (aa) type I transmembrane protein.  It contains a large 762 amino acid (aa) extracellular domain (ECD) (aa 35-795) plus a 274 aa cytoplasmic region.  The ECD contains 17 LRRs (aa’s 35-491) and three C2-type Ig-like domains (aa’s 497-781).  These two domain types are each sufficient for EGFR binding.  There one potential alternative splice form that a deletion of aa 875-923.  The LRIG1 ECD undergoes proteolysis, generating 90-105 and 60-70 kDa soluble fragments.  Over aa 37-794, human LRIG1 shares 97% and 90% aa sequence identity with rat and human LRIG1, respectively.

Limitations

This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.

Publications for LRIG1 Antibody (FAB3688G)(4)

Publications using FAB3688G

• Morgan, HJ;Olivero, C;Shorning, BY;Gibbs, A;Phillips, AL;Ananthan, L;Lim, AXH;Martuscelli, L;Borgogna, C;De Andrea, M;Hufbauer, M;Goodwin, RG;Akgül, B;Gariglio, M;Patel, GK; HPV8-induced STAT3 activation led keratinocyte stem cell expansion in human actinic keratoses JCI insight 2024-06-25 [PMID: 38916963] (Flow Cytometry, Mouse)
• Georgina Goss, Emanuel Rognoni, Vasiliki Salameti, Fiona M. Watt Distinct Fibroblast Lineages Give Rise to NG2+ Pericyte Populations in Mouse Skin Development and Repair Frontiers in Cell and Developmental Biology 2021-05-28 [PMID: 34124060]
• Beate M. Lichtenberger, Maria Mastrogiannaki, Fiona M. Watt Epidermal beta -catenin activation remodels the dermis via paracrine signalling to distinct fibroblast lineages Nature Communications 2016-02-03 [PMID: 26837596]
• Emily J. Poulin, Anne E. Powell, Yang Wang, Yina Li, Jeffrey L. Franklin, Robert J. Coffey Using a new Lrig1 reporter mouse to assess differences between two Lrig1 antibodies in the intestine Stem Cell Research 2014-11-01 [PMID: 25460603]

Bioinformatics

• Gene Symbol: Lrig1
• Uniprot:
  • P70193()